Alizon, F., S.B. Shooter, and T.W. Simpson. 2009. Henry Ford and the Model T: Lessons for product platforming and mass customization. Design Studies 30(5): 588–605.
Baltimore, D., F. Baylis, P. Berg, G.Q. Daley, J.A. Doudna, E.S. Lander, R. Lovell-Badge, P. Ossorio, D. Pei, A. Thrasher, E. Winnacker, and Q. Zhou. 2015a. On human gene editing: International summit statement. http://www8.nationalacademies.org/onpinews/newsitem.aspx?RecordID=12032015a (Press Release).
Baltimore, D., P. Berg, M. Botchan, D. Carroll, R.A. Charo, G. Church, J.E. Corn, G.Q. Daley, J.A. Doudna, M. Fenner, H.T. Greely, M. Jinek, S.G. Martin, E. Perhoet, J. Puck, S.H. Sternberg, J.S. Weissman, and K.R. Yamamoto. 2015b. A prudent path forward for genomic engineering and germline gene modification. Science 348(6230): 36–38.
Barrangou, R. 2014. Cas9 targeting and the CRISPR revolution. Science 344(6185): 707–708.
Bostrom, N. 2007. Technological revolution: Ethics and policy in the dark. In Nanoscale: Issues and perspectives for the nano century, ed. M. Nigel, S. de Cameron, and E.M. Mitchell, 129–152. New York: Wiley.
Brunet, T.D.P. 2016. Aims and methods of biosteganography. Journal of Biotechnology 226: 56–64.
Carroll, D. 2014. Genome engineering with targetable nucleases. Annual Review of Biochemistry 83: 409–439.
Carroll, S.B. 2008. Evo-devo and an expanding evolutionary synthesis: a genetic theory of morphological evolution. Cell 134(1): 25–36.
Charo, R.A., and H.T. Greely. 2015. CRISPR critters and CRISPR cracks. The American Journal of Bioethics 15(12): 11–17.
Christenson, C. 1997. The innovator’s dilemma. Cambridge, MA: Harvard Business School Press.
Chung, E. 2015. Synbiota biohacking kits let you do genetic engineering at home. CBC News, October 15. http://www.cbc.ca/news/technology/biohacking-diy-bio-1.3252735. Retrieved November 4, 2015.
Collingridge, D. 1980. The social control of technology. London: Pinter.
Colman, A. 2008. Stem cell research in Singapore. Cell 132(4): 519–521.
Cong, L., F.A. Ran, D. Cox, S. Lin, R. Barretto, N. Habib, P.D. Hsu, et al. 2013. Multiplex genome engineering using CRISPR/Cas systems. Science 339(6121): 819–823.
Cowan, C. 2015. Measuring off-target events, efficiency, and utility. Presentation, information-gathering meeting for the planning committee organizing the international summit on human gene editing, October 5, Washington, DC.
Davies, M.J., V.M. Moore, K.J. Willson, P. Van Essen, K. Priest, H. Scott, E.A. Haan, and A. Chan. 2012. Reproductive technologies and the risk of birth defects. New England Journal of Medicine 366(19): 1803–1813.
Dhar, D., and J. Hsi-en Ho. 2009. Stem cell research policies around the world. The Yale Journal of Biology and Medicine 82(3): 113–115.
DiCarlo, J.E., J.E. Norville, P. Mali, X. Rios, J. Aach, and G.M. Church. 2013. Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems. Nucleic Acids Research 41(7): 4336–4343.
Ding, Q., S.N. Regan, Y. Xia, L.A. Oostrom, C.A. Cowan, and K. Musunuru. 2013. Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs. Cell Stem Cell 12(4): 393.
Duncan, J. 2011. Any colour-so long as it’s black: Designing the Model T Ford 1906–1908. New Zealand: Exisle Publishing.
Esvelt, K.M., A.L. Smidler, F. Catteruccia, and G.M. Church. 2014. Concerning RNA-guided gene drives for the alteration of wild populations. Elife 3: e03401.
Friedland, A.E., Y.B. Tzur, K.M. Esvelt, M.P. Colaiácovo, G.M. Church, and J.A. Calarco. 2013. Heritable genome editing in C. elegans via a CRISPR-Cas9 system. Nature Methods 10(8): 741–743.
Friedmann, T., and R. Roblin. 1972. Gene therapy for human genetic disease? Science 175(4025): 949–955.
Gallo, M., and R. Sayre. 2009. Removing allergens and reducing toxins from food crops. Current Opinion in Biotechnology 20(2): 191–196.
Gantz, V.M., N. Jasinskiene, O. Tatarenkova, A. Fazekas, V.A. Macias, E. Bier, and A.A. James. 2015. November 23). Highly efficient Cas9-mediated gene drive for population modification of the malaria vector mosquito Anopheles stephensi. Proceedings of the National Academy of Sciences 112(49): E6736–E6743.
Gibson, D.G., G.A. Benders, C. Andrews-Pfannkoch, E.A. Denisova, H. Baden-Tillson, J. Zaveri, T.B. Stockwell, et al. 2008. Complete chemical synthesis, assembly, and cloning of a Mycoplasma genitalium genome. Science 319(5867): 1215–1220.
Gratz, S.J., A.M. Cummings, J.N. Nguyen, D.C. Hamm, L.K. Donohue, M.M. Harrison, J. Wildonger, and K.M. O’Connor-Giles. 2013. Genome engineering of Drosophila with the CRISPR RNA-guided Cas9 nuclease. Genetics 194(4): 1029–1035.
Harris, J. 2016. Germline modification and the burden of human existence. Cambridge Quarterly of Healthcare Ethics 25(1): 1–13.
Hosman, E. 2015. Gene therapy: Comeback? Cost-prohibitive? Biopoliticaltimes.org, November 19. http://www.biopoliticaltimes.org/article.php?id=8991. Retrieved November 20, 2015.
Hwang, W.Y., Y. Fu, D. Reyon, M.L. Maeder, S.Q. Tsai, J.D. Sander, R.T. Peterson, J.R.J. Yeh, and J.K. Joung. 2013. Efficient genome editing in zebrafish using a CRISPR-Cas system. Nature Biotechnology 31(3): 227–229.
Ingrassia, P. 2008. This car changed America: A look at Ford’s Model T, which debuted 100 years ago. Wall Street Journal, September 27. http://www.wsj.com/articles/SB122246777029780525. Retrieved November 24, 2015.
Jiang, W., D. Bikard, D. Cox, F. Zhang, and L.A. Marraffini. 2013. RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nature Biotechnology 31(3): 233–239.
Jinek, M., A. East, A. Cheng, S. Lin, E. Ma, and J.A. Doudna. 2013. RNA-programmed genome editing in human cells. Elife 2: e00471.
Kennedy, E.M., and B.R. Cullen. 2015. Bacterial CRISPR/Cas DNA endonucleases: A revolutionary technology that could dramatically impact viral research and treatment. Virology 479: 213–220.
Kline, R., and T. Pinch. 1996. Users as agents of technological change: The social construction of the automobile in the rural United States. Technology and Culture 37(4): 763–795.
Kutter, S. 2015. Gene therapy conquered: The 1-million-euro syringe. Wirtschafts Woche Medicine, April 4. http://www.wiwo.de/technologie/forschung/gen-therapie-erobert-deutschland-die-1-million-euro-spritze/11499176-all.html. Retrieved November 4, 2015.
Lanphier, E., F. Urnov, S.E. Haecker, M. Werner, and J. Smolenski. 2015. Don’t edit the human germ line. Nature 519(7544): 410–411.
Larson, C. 2015. China’s bold push into genetically customized animals. Science American, November 17. http://www.scientificamerican.com/article/china-s-bold-push-into-genetically-customized-animals/. Retrieved November 20, 2015.
Ledford, H. 2015. CRISPR, the disruptor. Nature 522(7554): 20–24.
Lewis, T. 2015. Chinese scientists want to sell these teensy genetically-engineered pigs as pets. Business Insider, September 30. http://www.businessinsider.com/chinese-genetically-engineered-mini-pigs-2015-9. Retrieved November 4, 2015.
Li, D., Z. Qiu, Y. Shao, Y. Chen, Y. Guan, M. Liu, Y. Li, et al. 2013a. Heritable gene targeting in the mouse and rat using a CRISPR-Cas system. Nature Biotechnology 31(8): 681–683.
Li, F.D., Y. Li, H. Liu, H.H. Zhang, C.X. Liu, X.J. Zhang, H.W. Dou, W.X. Yang, and Y.T. Du. 2014. Production of GHR double-allelic knockout Bama pig by TALENs and handmade cloning. Yi Chuan 36(9): 903–911.
Li, J.F., J.E. Norville, J. Aach, M. McCormack, D. Zhang, J. Bush, G.M. Church, and J. Sheen. 2013b. Multiplex and homologous recombination-mediated genome editing in Arabidopsis and Nicotiana benthamiana using guide RNA and Cas9. Nature Biotechnology 31(8): 688–691.
Li, W., F. Teng, T. Li, and Q. Zhou. 2013c. Simultaneous generation and germline transmission of multiple gene mutations in rat using CRISPR-Cas systems. Nature Biotechnology 31(8): 684–686.
Liang, P., Y. Xu, X. Zhang, C. Ding, R. Huang, Z. Zhang, J. Lv, et al. 2015. CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes. Protein & Cell 6(5): 363–372.
Mali, P., L. Yang, K.M. Esvelt, J. Aach, M. Guell, J.E. DiCarlo, J.E. Norville, and G.M. Church. 2013. RNA-guided human genome engineering via Cas9. Science 339(6121): 823–826.
Mariscal, C. 2015. Universal biology: Assessing universality from a single example. In The impact of discovering life beyond earth, ed. S. Dick. Cambridge: Cambridge University Press.
Moor, J.H. 2005. Why we need better ethics for emerging technologies. Ethics and Information Technology 7(3): 111–119.
Morange, M. 2015. Genetic modification of the human germ line: The reasons why this project has no future. Comptes Rendus Biologies 338(8): 554–558.
Nekrasov, V., B. Staskawicz, D. Weigel, J.D.C. Jones, and S. Kamoun. 2013. Targeted mutagenesis in the model plant Nicotiana benthamiana using Cas9 RNA-guided endonuclease. Nature Biotechnology 31(8): 691–693.
Nriagu, J.O. 1990. The rise and fall of leaded gasoline. Science of the Total Environment 92: 13–28.
Peng, Z. 2005. Current status of gendicine in China: Recombinant human Ad-p53 agent for treatment of cancers. Human Gene Therapy 16(9): 1016–1027.
Räty, J.K., J.T. Pikkarainen, T. Wirth, and S. Ylä-Herttuala. 2008. Gene therapy: The first approved gene-based medicines, molecular mechanisms and clinical indications. Current Molecular Pharmacology 1(1): 13–23.
Reardon, S. 2015. Leukaemia success heralds wave of gene-editing therapies. Nature News 527(7577): 146–147. http://www.nature.com/news/leukaemia-success-heralds-wave-of-gene-editing-therapies-1.18737. Retrieved November 5, 2015.
Sander, J.D., E.J. Dahlborg, M.J. Goodwin, L. Cade, F. Zhang, D. Cifuentes, S.J. Curtin, S.J. Blackburn, S. Thibodeau-Beganny, Y. Qi, C.J. Pierick, E. Hoffman, M.L. Maeder, C. Khayter, D. Reyon, D. Dobbs, D.M. Langenau, R.M. Stupar, A.J. Giraldez, D.F. Voytas, R.T. Peterson, J.R.J. Yeh, and J.K. Joung. 2011. Selection-free zinc-finger-nuclease engineering by context-dependent assembly (CoDA). Nature Methods 8(1): 67–69.
Sherkow, J.S., and H.T. Greely. 2013. What if extinction is not forever? Science 340(6128): 32–33.
Sigma-Aldrich. 2011. Sigma® life science reaches milestone in gene editing with increased affordability for CompoZr® ZFNs and the expansion of knockout ZFNs to include every gene in mice and rats advances in technology platform and new production center result in more content and less expensive Compozr ZFNs. http://investor.sigmaaldrich.com/releasedetail.cfm?ReleaseID=596302. Retrieved November 4, 2015.
Sontheimer, E.J., and R. Barrangou. 2015. The bacterial origins of the CRISPR genome-editing revolution. Human Gene Therapy 26(7): 413–424.
Specter, M. 2015. The gene hackers. The New Yorker, November 16. http://www.newyorker.com/magazine/2015/11/16/the-gene-hackers. Retrieved November 20, 2015.
Sturgeon, T., and Florida, R. (2000). Globalization and jobs in the automotive industry. Final report to the Alfred P. Sloan Foundation. International Motor Vehicle Program, Center for Technology, Policy, and Industrial Development, Massachusetts Institute of Technology. https://www.creativeclass.com/rfcgdb/articles/2000-The_World_That_Changed_The_Machine_Globalization_And_Jobs_In_The_Automotive_Industry.pdf. Retrieved November 5, 2015.
U.S. Food and Drug Administration (FDA). 2015. Cellular and gene therapy products, October 20. http://www.fda.gov/biologicsbloodvaccines/cellulargenetherapyproducts/default.htm. Retrieved November 4, 2015.
Waltz, E. 2016. Gene-edited CRISPR mushroom escapes US regulation. Nature News 532: 293.
Wang, H., H. Yang, C.S. Shivalila, M.M. Dawlaty, A.W. Cheng, F. Zhang, and R. Jaenisch. 2013. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 153(4): 910–918.
Williams, K., C. Haslam, and J. Williams. 1992. Ford versus Fordism: The beginning of mass production? Work, Employment & Society 6(4): 517–555.
Wilson, J.M. 2005. Gendicine: The first commercial gene therapy product; Chinese translation of editorial. Human Gene Therapy 16(9): 1014–1015.
Womack, J.P., D.T. Jones, and D. Roos. 1990. The machine that changed the world. New York: Rawson Associates.
Yang, L., M. Güell, D. Niu, H. George, E. Lesha, D. Grishin, J. Aach, et al. 2015. Genome-wide inactivation of porcine endogenous retroviruses (PERVs). Science 350(6264): 1101–1104.
Yeadon, J. 2015. Pros and cons of ZFNs, TALENs, and CRISPR/Cas. https://www.jax.org/news-and-insights/jax-blog/2014/march/pros-and-cons-of-znfs-talens-and-crispr-cas. Retrieved November 4, 2015.
Zhang, L., and Q. Zhou. 2014. CRISPR/Cas technology: a revolutionary approach for genome engineering. Science China Life Sciences 57(6): 639–640.
Zhou, Q. 2015. Overview of Chinese gene editing research and policy. Question and answer period, information-gathering meeting for the planning committee organizing the international summit on human gene editing, October 5, Washington, DC.
Zimmer, C. 2013. Bringing them back to life. National Geographic 223(4): 28.